購読する
モデル製品
サービス
前臨床薬効評価
コミュ二ティー
Lyz2-IRES-CreERT2 Mouse
製品のお見積りを依頼する
当社のカタログから製品を選択してご注文ください。当社チームが詳細な情報をご連絡いたします。
Lyz2-IRES-CreERT2 Mouse
製品名
Lyz2-IRES-CreERT2 Mouse
製品ID
C001499
系統名
C57BL/6JCya-Lyz2em3(IRES-CreERT2)/Cya
背景情報
C57BL/6JCya
組織や細胞を表現する例
Bone marrow cell lineages (monocytes, mature macrophages, and granulocytes)
状況
このマウス系統を論文で使用する場合は、「Lyz2-IRES-CreERT2 Mouse(カタログ番号C001499)はサイアジェンから購入しました。」と引用してください。
Inducible Cre Mouse Models
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
お見積もりについてはこちらまでご連絡ください
Inducible Cre Mouse Models
基本情報
検証 Data
関連リソース
基本情報
遺伝子名
遺伝子別名
Lys, Lzm, Lzp, Lysm, Lyzs, Lyzf2, Lzm-s1
NCBI ID
染色体
Chr 10
MGI ID
さらに
系統詳細
Lysozyme, encoded by the LYZ gene, is an integral component of the innate immune system. Its primary function is to disrupt bacterial cell walls by cleaving the β-1,4-glycosidic bond between N-acetylmuramic acid and N-acetylglucosamine in bacterial peptidoglycan, leading to bacterial lysis. Lysozyme is abundant in various secretions, including tears, saliva, human milk, and mucus, as well as in the cytoplasmic granules of macrophages and polymorphonuclear neutrophils. Cytoplasmic lysozyme expression is high in bone marrow cells, Paneth cells, and a subset of salivary gland cells [1-2].
Mice have two lysozyme-encoding genes, Lyz1 and Lyz2, which are highly homologous to the human LYZ gene. Lyz1 is primarily expressed in Paneth cells, while Lyz2 is mainly expressed in myeloid cells. Myeloid-specific expression of Lyz2 is associated with cell-type-specific demethylation of its downstream enhancer. The Lyz2 protein also has lysozyme activity and participates in defense responses against both Gram-negative and Gram-positive bacteria. Lyz2 is expressed in the hematopoietic system, liver, mesothelium, small intestine, and yolk sac of mice [3-4].
Lyz2-IRES-CreERT2 mice were generated using gene editing technology to integrate the tamoxifen-inducible CreERT2 recombinase expression element into the 3’UTR of the mouse Lyz2 gene. This mimics the expression pattern of the endogenous gene while maintaining Lyz2 expression. When bred with mice carrying a loxP site-flanked sequence, Cre recombinase-mediated recombination of the flanked sequence occurs in myeloid cells, including monocytes, mature macrophages, and granulocytes, following tamoxifen induction.
参考文献
Yoshimura K, Toibana A, Nakahama K. Human lysozyme: sequencing of a cDNA, and expression and secretion by Saccharomyces cerevisiae. Biochem Biophys Res Commun. 1988 Jan 29;150(2):794-801.
Sharon N. The chemical structure of lysozyme substrates and their cleavage by the enzyme. Proc R Soc Lond B Biol Sci. 1967 Apr 18;167(1009):402-15.
Peters CW, Kruse U, Pollwein R, Grzeschik KH, Sippel AE. The human lysozyme gene. Sequence organization and chromosomal localization. Eur J Biochem. 1989 Jul 1;182(3):507-16.
Clausen BE, Burkhardt C, Reith W, Renkawitz R, Förster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 1999 Aug;8(4):265-77.
系統作製戦略
The IRES-CreERT2 gene expression element was integrated into the 3'UTR region of the mouse Lyz2 gene using gene editing technology.

Figure 1. Diagram of the gene editing strategy for the generation of Lyz2-IRES-CreERT2 mice.
検証 Data
1. Method
Lyz2-IRES-CreERT2 mice were mated with Rosa26-LSL-tdTomato mice to generate double heterozygous zygote mice. Tamoxifen induction (3 mg/mouse for 3 days, i.p.) was performed at 8 weeks of age, resulting in Cre recombinase-mediated deletion of the LSL elements and subsequent expression of tdTomato in Cre-positive cells. One week after induction, peripheral blood was collected from the offspring, and the distribution of tdTomato was determined by flow cytometry to assess Cre recombinase expression. The control group received the same dose of corn oil.
2. Groups
Cre+Tam+: Lyz2-IRES-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+],Tamoxifen;
Cre+Tam-: Lyz2-IRES-CreERT2[KI/+];Rosa26-LSL-tdTomato[CKI/+], Corn oil;
Cre-Tam+: Rosa26-LSL-tdTomato[CKI/CKI], Tamoxifen.
3. Result
(1)Cre recombinase expression in peripheral blood
Cre recombinase activity and specificity were assessed in mouse peripheral blood macrophages (CD45+Cd11b+) by FACS analysis of tdTomato protein expression. Strong Cre recombinase activity was detected in macrophages from tamoxifen-induced double heterozygous mice (Cre+Tam+), with more than 90% of macrophages tdTomato-positive. However, Cre recombinase activity was undetectable in both tamoxifen-untreated double heterozygous mice (Cre+Tam-) and tamoxifen-treated Rosa26-LSL-tdTomato mice (Cre-Tam+). These results demonstrate high Cre recombinase activity and specificity under this induction regimen, with no evidence of expression leakage.

Figure 2. FACS analysis of peripheral blood macrophages.
4. Summary
In Lyz2-IRES-CreERT2 mice, Cre recombinase activity is extremely high in peripheral blood macrophages, with no evidence of pre-induction leaky expression. Our internal data show that Cre recombinase recombination efficiency in macrophages can exceed 90% following the experimental induction protocol. However, recombination efficiency drops to approximately 13% 14 days after induction is complete. Additionally, when the induction protocol is adjusted to 2 mg tamoxifen per mouse per day for 3 or 5 days, or 4 mg tamoxifen per mouse per day for 3 days, recombination efficiency in peripheral blood CD45+Cd11b+ cells is approximately 40% one week after induction is complete (data not shown).
関連リソース
お問い合わせ
ご不明な点やご質問などございましたら、お気軽にお問い合わせください。担当スタッフがサポートさせていただきます。下記のフォームにご記入いただければ、1〜2営業日以内に折り返しご連絡いたします。
Related Product
All Related ProductsResources
お問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
